Skip to content
Research/Peptides/CJC-1295 No DAC (Modified GRF 1-29)

CJC-1295 No DAC (Modified GRF 1-29)

Mod GRF 1-29, CJC No DAC. Short-acting GHRH analog without DAC modification. Creates a high, pulsatile GH release, more natural GH stimulation. Combined with Ipamorelin for synergistic effects.

Intelligence Profile

Research Papers

Research Papers and Clinical Trials

No published research was found for CJC-1295 No DAC (Modified GRF 1-29) in major medical databases or clinical trial registries.

This absence of peer-reviewed studies means there is currently no scientific evidence available regarding the safety, efficacy, dosing, or clinical effects of this compound. Without published research or registered clinical trials, claims about this substance cannot be evaluated against established medical evidence.

The lack of research data represents a significant knowledge gap. Any use of this compound would be considered experimental, as its effects in humans have not been systematically studied or documented in the medical literature.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Consult with a healthcare provider before considering any experimental compounds or treatments.

Free account required

Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.